tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MRK Stock Latest News

Unusually active option classes on open April 30th
The FlyUnusually active option classes on open April 30th
2d ago
AUR
BKR
Merck price target lowered to $108 from $115 at Guggenheim
PremiumThe Fly
Merck price target lowered to $108 from $115 at Guggenheim
2d ago
MRK
Merck & Co. (MRK) Looks to New Cholesterol Drug as Keytruda Expiration Looms
PremiumMarket News
Merck & Co. (MRK) Looks to New Cholesterol Drug as Keytruda Expiration Looms
3d ago
MRK
Dow Jones Index Today: Earnings Season Boosts DIA Stock
PremiumMarket News
Dow Jones Index Today: Earnings Season Boosts DIA Stock
3d ago
CVX
DIA
Merck Has a $1B Plan to Avoid Tariffs
PremiumMarket News
Merck Has a $1B Plan to Avoid Tariffs
3d ago
MRK
Merck starts construction on new $1B biologics center in Delaware
PremiumThe FlyMerck starts construction on new $1B biologics center in Delaware
4d ago
MRK
Merck plans to spend $1B on new plant in Delaware, WSJ says
Premium
The Fly
Merck plans to spend $1B on new plant in Delaware, WSJ says
4d ago
MRK
Merck price target lowered to $100 from $115 at HSBC
Premium
The Fly
Merck price target lowered to $100 from $115 at HSBC
5d ago
MRK
Merck & Co.’s Strategic Resilience and Growth Potential Amidst Macroeconomic Challenges
PremiumRatings
Merck & Co.’s Strategic Resilience and Growth Potential Amidst Macroeconomic Challenges
5d ago
MRK
Merck’s Earnings Call: Growth Potential and Challenges
PremiumCompany Announcements
Merck’s Earnings Call: Growth Potential and Challenges
7d ago
MRK
BMO says Keytruda ‘still reigns’ after ivonescimab survival data
PremiumThe Fly
BMO says Keytruda ‘still reigns’ after ivonescimab survival data
7d ago
MRK
BNTX
Akeso survival data for ivonescimab misses expectations, STAT says
PremiumThe Fly
Akeso survival data for ivonescimab misses expectations, STAT says
7d ago
MRK
BNTX
ALX Oncology reports ASPEN-03, ASPEN-04 trials did not meet primary endpoints
PremiumThe FlyALX Oncology reports ASPEN-03, ASPEN-04 trials did not meet primary endpoints
7d ago
MRK
ALXO
Merck price target lowered to $82 from $89 at BMO Capital
Premium
The Fly
Merck price target lowered to $82 from $89 at BMO Capital
7d ago
MRK
Merck & Co. Hold Rating: Gardasil Challenges and Keytruda Exclusivity Concerns Weigh on Market Performance
Premium
Ratings
Merck & Co. Hold Rating: Gardasil Challenges and Keytruda Exclusivity Concerns Weigh on Market Performance
8d ago
MRK
Merck & Co. Rated ‘Buy’ by Analyst Tim Anderson for Growth Potential and Undervaluation
PremiumRatings
Merck & Co. Rated ‘Buy’ by Analyst Tim Anderson for Growth Potential and Undervaluation
8d ago
MRK
Merck Reports Mixed Q1 2025 Financial Results
PremiumCompany Announcements
Merck Reports Mixed Q1 2025 Financial Results
8d ago
MRK
Morning Movers: Mobileye jumps following first quarter earnings
PremiumThe Fly
Morning Movers: Mobileye jumps following first quarter earnings
8d ago
FI
PG
Halozyme sues Merck for patent infringement over subcutaneous Keytruda
PremiumThe Fly
Halozyme sues Merck for patent infringement over subcutaneous Keytruda
8d ago
MRK
HALO
MRK Earnings: Merck & Company Fears $200M Tariff Hit but Pet Drugs Give Bite to Q1 Sales
PremiumMarket NewsMRK Earnings: Merck & Company Fears $200M Tariff Hit but Pet Drugs Give Bite to Q1 Sales
8d ago
MRK
Options Volatility and Implied Earnings Moves Today, April 24, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, April 24, 2025
9d ago
PG
AAL
Merck sees $200M hit from tariffs in 2025
Premium
The Fly
Merck sees $200M hit from tariffs in 2025
9d ago
MRK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >